Abstract: A novel process for preparing enantiomerically-pure 3-methyl-5-(1-(C.sub.1 -C.sub.3 -alkyl)-2-pyrrolidinyl)isoxazole in high yield, wherein a protected pyrrolidine or 2-oxo-pyrrolidine starting material is reacted with a suitable organic anion and a resulting beta-keto oxime intermediate is cyclized and dehydrated, as well as intermediates useful in the preparation thereof.

Abstract: Compounds of the formula: ##STR1## useful as regulators of nitric oxide synthase that indirectly modulate cyclic guanosine monophosphate (cGMP), pharmaceutical compositions thereof, for treating disorders of vascular smooth muscles, macrophages, neurons, platelets, bronchial smooth muscles, optic muscles and gastrointestinal smooth muscles, sickle cell anemia and diabetes.

Abstract: 2-Nitroaryl or 2-cyanoaryl compounds of the formula ##STR1## pharmaceutical compositions thereof, intermediates useful in the preparation of these compounds, and methods for treating disorders of vascular smooth muscles or diseases of the cartilage, macrophages, neurons, platelets, bronchial smooth muscles, optic muscles and gastrointestinal smooth muscles, in addition to sickle cell anemia, diabetes, synovitis, chondroarthritis and osteoarthritis by employing these compounds.

Abstract: Selective and potent nicotinic agonists of the formula: ##STR1## including pharmaceutically-acceptable salts or prodrugs thereof, useful in the treatment of dementias, attentional hyperactivity disorder, anxiety associated with cognitive impairment, or substance abuse withdrawal characterized by decreased cholinergic function.

Abstract: Pharmaceutical compositions comprising a therapeutically effective amount of (+) 2-methylpiperidine and a pharmaceutically-acceptable carrier or diluent, as well as to a method of treating cognitive, neurological and mental disorders, which are characterized by decreased cholinergic function in humans and lower mammals, by administration of (+)2-methylpiperidine, optionally with a nicotinic agonist.

Abstract: A novel nitritional formulation comprising mixtures of mixed salts formed between branched-chain .alpha.-keto-acids and basic L-amino acid is disclosed which provides optimal nutrition when consumed with a very low protein diet. The composition of this invention contains fewer components than other mixtures utilized heretofore while maintaining like proportions of the essential and semi-essential amino acids. The composition of this invention has improved thermal stability and taste and is useful for the nutritional treatment of chronic renal failure (uremia).

Abstract: An enteral delivery universal port assembly fabricated from a first portion and a second portion of different materials. The first portion has a generally cylindrical side wall, an annular top surface and a corresponding annular bottom surface. The second portion has a central portion with a peripheral flange extending radially outward therefrom, and an annular portion positionable is superposed adjacent relationship to the annular bottom surface. Extending upwardly from the surface of the central portion are first and second projections, the first projection having a base which is a spikable membrane and the second projection being associated with filter means which allow air to enter the enteral nutritional product container to which the enteral delivery universal port assembly is secured in its operative embodiment.

Abstract: A closure containing an internalized microbial filter for use in enteral delivery set assemblies. The closure comprises a generally cylindrical side wall, a planar top surface having first and second projections, the first projection being associated with the spikable membrane while the second projection is associated with a filter and with means to limit air access to the filter. The closure also includes a bottom surface having an aperture which extends through the closure to the top surface thereof with the filter being secured to the bottom surface and extending across the opening of the aperture.

Abstract: An improved nutritionally complete formula containing a unique fiber-containing carbohydrate blend, at a relatively low concentration; a unique fat blend, at a relatively high concentration; protein; carnitine; myoinositol; vitamins and minerals, including chromium. This formula is for the dietary management of patients with glucose intolerance.

Abstract: An improved system for initially positioning and for continuous or intermittent monitoring of the location of the distal end of a feeding tube in a patient's gastrointestinal tract and for selectively controlling a feeding device associated therewith by detecting and processing myoelectric signals unique to different areas of the gastrointestinal tract, such signals being detected by electrodes carried by the distal end of the feeding tube and transmitted by leads extending through the feeding tube to a monitor.

Abstract: Disclosed are ultrafiltration processes for the enrichment and concentration of selected proteins from protein conaining fluids. Illustratively, IgG is concentrated from whey by means of multiple ultrafiltration "passes", using a metallic oxide ultrafiltration membrane, which are characterized by differing pH's.

Abstract: A sample processor card for use with a centrifuge in which the direction of centrifugal force can be altered at will, wherein the card includes a supply of chemical reagent and inlet means for supplying a chemical sample to the card. The sample is advanced under centrifugal force through capillary means to sample measuring means, and the measured sample is then mixed with reagent to permit a chemical test to be carried out on the reagent, all under centrifugal force.

Abstract: The present invention includes compounds represented by the formula: ##STR1## wherein R.sub.1 is a hydroxy, a C.sub.1 to C.sub.6 alkoxy, benzoxy, or an alkylcarbonyloxymethoxy group, or R.sub.3 together with R.sub.1 forms a group of the formula --Y--NH-- where Y is oxygen or sulfur; or R.sub.3 is hydrogen; A is nitrogen or CR.sub.2, where R.sub.2 is hydrogen, or halogen, or R.sub.2 together with R forms a group of the formula --X--CH.sub.2 --CH(R.sub.6)-- or --X--CH.sub.2 --CH.dbd.CH.sub.2, wherein X is CH.sub.2, O, S, NH, or NCH.sub.3, and R.sub.6 is hydrogen, alkyl, or C.sub.1 -C.sub.3 haloalkyl; or R is (1) a C.sub.1 to C.sub.4 alkyl, (2) lower cycloalkyl, (3) alkylamino, (4) haloalkyl, (5) an aromatic heterocyclic ring or (6) a substituted phenyl group; and Z is a carbocyclic group;or a pharmaceutically acceptable salt thereof. The compounds of the present invention are useful as antibacterial agents.

Abstract: An expedited process for the dispersion and neutralization of acid caseins in the manufacture of liquid caseinate that drastically reduces time and cost variables and allows for in-house production of caseinate. The process comprises the initial addition of a solubilizing agent (i.e. citrate) to an aqueous solution with a temperature of about 120.degree. F. to about 165.degree. F. prior to the addition of casein and a neutralizing agent. This process achieves a pH-perfect, soluble caseinate product in the form of a ready-to-use liquid or powdered caseinate.

Abstract: This invention relates to a system for printing and dispensing chemical reagents in precisely controlled volumes onto a medium at a precisely controlled location. A jetting tube, comprising an orifice at one end and a fluid receiving aperture at the other end, is concentrically mounted within a cylindrical piezo-electric transducer. The fluid receiving aperture is connected to a reservoir containing a selected reagent by means of a filter. The reservoir may be pressurized by a regulated air supply. An electrical signal of short duration is applied to the transducer. The pulse causes the transducer and the volume defined by the jetting tube to expand, thereby drawing in a small quantity of reagent fluid. The cessation of the pulse causes the transducer and the volume of the jetting tube to de-expand, thereby causing at least a substantially uniformly sized droplet of reagent fluid to be propelled through the orifice.

Abstract: A method of preventing the fracture of coated drug granules during the compression of the granules into a commercially acceptable tablet matrix is disclosed. The method involves incorporating into the matrix, along with the granules, from about 10% to about 50% by weight microcrystalline cellulose.

Abstract: A tablet providing enhanced delivery of an acid-sensitive drug in conjunction with an acid-stable drug is disclosed. The tablet is made up of a matrix containing a major proportion of an acid-stable drug, and a minor proportion of microcrystalline cellulose. Embedded in the matrix are coated granules containing at least about 90% of an acid-sensitive drug by weight, exclusive of the coating, and having a particle size of from about 10 to about 40 mesh. The granules of acid-sensitive drug have an acid resistant and/or enteric coating selected to dissolve in less than sixty minutes at a pH of 5.5 or greater.

Abstract: A heating system for heating a rapidly rotating article, including a strobe capable of emitting radiant energy and positioned to radiate energy onto the article, a light source positioned to illuminate a temperature-sensing means on the article, a light detector to measure changes in the light reflected by the temperature-sensor and a control device to energize the strobe in response to reflected light from the detector.

Abstract: An enteral feeding catheter is characterized by being adapted for introduction through the mouth via a guidewire that extends from the mouth through the esophagus, stomach and abdominal puncture. The catheter has a relatively stiff leading portion of length sufficient to extend along the guidewire from the mouth through the abdominal puncture and of stiffness sufficient to permit it to be pushed along the guidewire, at least an initial length of the catheter being tapered to a narrow leading tip to enable the puncture to be dilated as its drawn therethrough. The catheter also has a relatively soft, large diameter trailing portion connected to the leading portion adapted to be drawn along said guidewire by grasping and pulling the stiff leading portion until the leading end of the soft portion extends outside the body through the widened puncture, while the trailing end remains in the stomach, whereby the relatively soft trailing portion can serve as a conduit for enteric feeding.

Abstract: Compositions which comprise a complex of carbomer (acrylic acid polymers) and erythromycin or a derivative thereof such as 6-O-methylerythromycin, are disclosed. The compositions provide nontoxic, palatable dry and liquid dosage forms for oral administration.